Literature DB >> 31312665

Estimation of the Incidence of Guillain-Barré Syndrome During Pregnancy in the United States.

Tanya R Myers1, Natalie L McCarthy1, Lakshmi Panagiotakopoulos1, Saad B Omer2,3.   

Abstract

Guillain-Barré syndrome (GBS) is an adverse event of interest after vaccination, yet few data are available for background rates during pregnancy. We confirmed 2 cases of incident GBS and estimated an incidence of 2.8 confirmed GBS cases per million person-years (95% confidence interval, 0.5-9.3), indicating rare occurrence. Our findings will help inform safety assessments of Zika vaccines in pregnant populations.

Entities:  

Keywords:  Guillain-Barré syndrome; Vaccine Safety Datalink; pregnancy

Year:  2019        PMID： 31312665      PMCID： PMC6419988          DOI： 10.1093/ofid/ofz071

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   3.835


  4 in total

1.  Monitoring the safety of COVID-19 vaccines in pregnancy in the US.

Authors:  Pedro L Moro; Lakshmi Panagiotakopoulos; Titilope Oduyebo; Christine K Olson; Tanya Myers
Journal:  Hum Vaccin Immunother       Date:  2021-11-10       Impact factor: 3.452

2.  Human DDX3X Unwinds Japanese Encephalitis and Zika Viral 5' Terminal Regions.

Authors:  Corey Nelson; Tyler Mrozowich; Darren L Gemmill; Sean M Park; Trushar R Patel
Journal:  Int J Mol Sci       Date:  2021-01-02       Impact factor: 5.923

3.  Facial Diplegia Variant of Guillain-Barré Syndrome in Pregnancy Following COVID-19 Vaccination: A Case Report.

Authors:  Adeel S Zubair; Ju Young Bae; Kunal Desai
Journal:  Cureus       Date:  2022-02-17

4.  Outcome of Guillain-Barré Syndrome (GBS) During Peripartum Period: A Hospital-Based Observational Study.

Authors:  Anil Kumar Patra; Marami Das; Saswati Sanyal Choudhury; Munindra Goswami; K Vanlalzami
Journal:  Ann Indian Acad Neurol       Date:  2022-06-21       Impact factor: 1.714
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.